9 active trials 6 recruiting 3 disease areas
| Early Phase 1 | 1 | |
| Phase 1 | 2 | |
| Phase 1/2 | 2 | |
| Phase 2 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT07244406 | Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL | B-ALL | Recruiting | 2025-11-24 |
| NCT07244380 | Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL. | T Lymphoblastic Leukemia/Lymphoma | Not Yet Recruiting | 2025-11-24 |
| Phase 1/2 | ||||
| NCT07421856 | Phase I/II Study of SENL103 for Relapsed or Refractory Multiple Myeloma: A Multicenter… | Multiple Myeloma in Relapse | Not Yet Recruiting | 2026-02-19 |
| NCT07161193 | Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases | Autoimmune Diseases | Not Yet Recruiting | 2025-09-08 |
| Phase 1 | ||||
| NCT05388695 | To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell… | 19 and 22+ B Cell Hematologic Tumors | Recruiting | 2025-06-18 |
| NCT06136364 | CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study | T-lymphoblastic Lymphoma | Recruiting | 2023-11-18 |
| Early Phase 1 | ||||
| NCT07435779 | Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A… | UC | Recruiting | 2026-02-27 |
| Not applicable | ||||
| NCT05618041 | The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With… | Acute Lymphoblastic Leukemia | Recruiting | 2025-06-24 |
| NCT05626400 | Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+… | T-cell Acute Lymphoblastic Leukemia/Lymphoma | Recruiting | 2022-11-25 |
Acute Lymphoblastic Leukemia (ALL) (5) · Leukemia (3) · Multiple Myeloma (2)